Mrs Megan Keller Boring, RN MSN APRN-BC | |
186 Airport Plaza Blvd, Alcoa, TN 37701-3182 | |
(865) 684-4810 | |
Not Available |
Full Name | Mrs Megan Keller Boring |
---|---|
Gender | Female |
Speciality | Clinical Nurse Specialist - Adult Health |
Location | 186 Airport Plaza Blvd, Alcoa, Tennessee |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639468937 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SA2200X | Clinical Nurse Specialist - Adult Health | 12499 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Megan Keller Boring, RN MSN APRN-BC 186 Airport Plaza Blvd, Alcoa, TN 37701-3182 Ph: (865) 684-4810 | Mrs Megan Keller Boring, RN MSN APRN-BC 186 Airport Plaza Blvd, Alcoa, TN 37701-3182 Ph: (865) 684-4810 |
News Archive
The link between obesity and the risk of endometrial cancer has been well documented. A new study, however, shows that an even lower body mass index (BMI) than previously thought can signal an increased risk in Asian women with postmenopausal bleeding. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).
Revolution Analytics, the leading provider of commercial software and support for the popular open source R statistics language, today announced the successful implementation of its signature product, Revolution R Enterprise, by biostatisticians at CardioDX, a genomic research firm.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new OsteoSense® 800 imaging agent for targeting areas of bone turnover and microcalcification in vivo. The new 800 nm OsteoSense agent complements VisEn's OsteoSense 680 and 750 products, and is expected to further expand the utilization of this agent family in enabling in vivo detection, measurement and monitoring of skeletal changes in a wide range of disease states, including arthritis, osteoporosis, and cancer metastasis.
Vodafone will be connecting the world's first and only exoskeleton that is FDA cleared for use with both stroke patients and spinal cord injuries – the Ekso GT™ from Ekso Bionics.
› Verified 1 days ago